Drug companies accused of stalling tailored therapies.
Sinha
Gunjan
G
D003920:Diabetes Mellitus / Q000188:drug therapy / Q000235:genetics; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D010597:Pharmacogenetics / Q000191:economics* / Q000592:standards; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D007328:Insulin; D013453:Sulfonylurea Compounds